On November 24, 2025 Bristol Myers Squibb (NYSE: BMY) reported that, following the conclusion of the American Society of Hematology (ASH) (Free ASH Whitepaper) Annual Meeting and Exposition, the company will hold a virtual investor event on Thursday, December 11, 2025, to highlight key Hematology programs.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The company will host a webcast beginning at 9:00 a.m. ET, which is accessible here. Company representatives will provide investors and analysts an overview of the company’s Hematology development strategy and review recent data.

A replay of the webcast will be available at View Source approximately three hours after the event concludes. Materials related to the webcast will be available at View Source at the start of the presentation.

(Press release, Bristol-Myers Squibb, NOV 24, 2025, View Source [SID1234660891])